<DOC>
<DOCNO>
EP-0001002
</DOCNO>
<TEXT>
<DATE>
19790307
</DATE>
<IPC-CLASSIFICATIONS>
C07C-209/00 <main>C07C-87/40</main> C07C-211/00 C07D-303/08 C07C-45/00 A61K-31/135 A61K-31/13 C07D-303/00 C07C-67/00 C07C-211/42 C07C-35/52 C07C-209/40 C07C-49/00 C07C-45/58 C07C-45/45 C07C-49/697 C07C-51/09 C07C-35/00 A61P-43/00 
</IPC-CLASSIFICATIONS>
<TITLE>
indanamines, processes for their preparation and compositions containing them.
</TITLE>
<APPLICANT>
smithkline corpus<sep>smithkline corporation<sep>smithkline beckman corporationp.o. box 7929 1 franklin plazaphiladelphia pennsylvania 19101us<sep>smithkline beckman corporation<sep>
</APPLICANT>
<INVENTOR>
bondinell william edward<sep>pendleton robert grubb<sep>bondinell, william edward<sep>pendleton, robert grubb<sep>bondinell, william edward46 curtis avenuecherry hill new jersey 08002us<sep>pendleton, robert grubb720 cornelia placephiladelphia pennsylvania 19118us<sep>bondinell, william edward<sep>pendleton, robert grubb<sep>bondinell, william edward46 curtis avenuecherry hill new jersey 08002us<sep>pendleton, robert grubb720 cornelia placephiladelphia pennsylvania 19118us<sep>
</INVENTOR>
<ABSTRACT>
2-indanamines substituted in the 4- and 5-position by  halogen or trifluoromethyl, which are inhibitors of phenylethanolamine  n-methyltransferase.  
</ABSTRACT>
</TEXT>
</DOC>
